Skip to main content

Table 1 Characteristics of subjects

From: Impact of visceral fat on gene expression profile in peripheral blood cells in obese Japanese subjects

N

17

Sex (male/female)

14/3

Age (years)

54.6 ± 14.6

BMI (kg/m2)

30 ± 5.5

Waist circumference (cm)

101 ± 11

Visceral fat area (cm2)

177 ± 67

Subcutaneous fat area (cm2)

245 ± 131

Adiponectin (μg/mL)

4.2 ± 1.7

Systolic blood pressure (mm Hg)

132 ± 17

Diastolic blood pressure (mm Hg)

82 ± 13.7

Fast plasma glucose (mg/dL)

102 ± 21

Hemoglobin A1c (%)

6.3 ± 1.3

Diagnosis (T2DM/B/N)

5/6/6

HOMA-IR

3.2 ± 2.3

Total cholesterol (mg/dL)

206 ± 40

Triglyceride (mg/dL)

196 ± 129

HDL-C (mg/dL)

56.3 ± 18.1

LDL-C (mg/dL)

114 ± 40

Uric acid (mg/dL)

6.4 ± 0.8

Urinary albumin (μg/day)

12.3 ± 10.6

eGFR (mL/min/1.73 m2)

77.9 ± 19.8

mean IMT ≥1.1 mm

7/10

Statin use (±)

7/10

ACE-I/ARB use (±)

4/13

  1. Data are mean ± SD
  2. T2DM type 2 diabetes mellitus, B borderline diabetes, N normal glucose tolerance, HOMA-IR homeostasis model assessment of insulin resistance, HDL-C high density lipoprotein-cholesterol, LDL-C low density lipoprotein-cholesterol, eGFR estimated glomerular filtration rate, IMT intima-media thickness, ACE-I angiotensin converting enzyme inhibitor, ARB angiotensin II receptor blocker